Category: Featured

  • Brazil: Tobacco Harvest ‘Inaugurated’

    Brazil: Tobacco Harvest ‘Inaugurated’

    SindiTabaco President Iro Schunke honors tobacco growers during a ceremony in Rio Grande do Sul celebrating the sector’s contributions. (Photo: SindiTabaco)

    Brazil leaf tobacco sector “inaugurated” the tobacco harvest on Oct. 28 in the Faxinal de Dentro district of Rio Grande do Sul. Promoted by the Secretariat of Agriculture, Livestock and Rural Development, the festivity is an official event of the state government and relies on support from the Interstate Tobacco Industry Union (SindiTabaco), Tobacco Growers’ Association of Brazil (Afubra) and the municipal administration of Vale do Sol.

    Speaking during the ceremony, SindiTabaco President Iro Schunke said the inauguration of the harvest, held on Tobacco Growers’ Day, is an excellent opportunity to acknowledge tobacco farmers’ social and economic contributions.

    “Approximately 10 percent of all Rio Grande do Sul exports last year consisted of tobacco shipments,” he said in a statement. “Several mayors report that, after the arrival of tobacco in their municipalities, things changed for the better, seeing that there was an increase in tax collection for the benefit of all citizens.”

  • Puff Bar CEOs Profiled

    Puff Bar CEOs Profiled

    Photo: Puff Bar

    The Wall Street Journal recently profiled Patrick Beltran and Nick Minas, co-CEOs of Puff Bar, a top-selling disposable e-cigarette brand in the United States.

    Puff Bar entered the U.S. market in 2019. At the time, it was owned by Cool Clouds Distribution of California. Cool Clouds sold the Puff Bar to the brand’s Chinese manufacturer, DS Technology Licensing, in early 2020.

    In February 2020, to curb youth vaping, the Food and Drug Administration implemented new restrictions excluding sweet and fruit flavors in reusable e-cigarettes such as those offered by Juul Labs. The restrictions did not apply to disposable devices such as Puff Bars.

    In the summer of 2020, however, the FDA ordered Puff Bar products off the market. Critics said the brand was replacing Juul as the vape of choice among young people as Juul discontinued certain flavored products. In February 2021 Puff Bar resumed sales with redesigned product containing synthetic nicotine, which remains outside the FDA’s purview.

    Minas and Beltran became executives of Puff Bar as CEO and CFO respectively in the spring of 2020, when the brand was taken over by two men and DS Technology as per company filings. The entrepreneurs owned and operated an online e-cigarette retailer called Eliquidstop.

    In the Wall Street Journal article, Beltran described the Puff Bar ingredient change as “a forced innovation,” saying that the FDA gave the company no choice.

    Puff Bar sales in retail stores tracked by Nielsen totaled $156 million for the year ended Sept. 25, according to Goldman Sachs, although it is unclear how many of those sales are counterfeit products. In a federal survey released in Sept., 26 percent of high-school vaporizers said they used Puff Bars. Among middle-school e-cigarette users, 30 percent reported that their generic brand was Puff Bars.

  • TMA Announces Virtual Annual Conference

    TMA Announces Virtual Annual Conference

    TMA will hold a virtual annual conference on Nov. 16-17, TMA 2021: From Chance to Change. As the industry has been challenged in many ways this year, TMA believes it is important to share insights among all stakeholders to equip its audience and members with the understanding and information necessary to successfully navigate the changes that lie ahead. TMA 2021 will feature two half-day interactive virtual sessions with keynotes from regulatory leaders and panel discussions from industry and stakeholder thought leaders that covers everything from Food and Drug Administration policy, marketing denial orders, product authorization pathways (PMTA, SE, MRTP, exemptions) and global trends that may surface in the U.S. and vice-versa.

    “For this year’s TMA Annual Conference, we felt it was important to capitalize on the breadth and depth of speakers and expertise that only TMA can bring and condense that into the most important topics for our attendees who have also spent the last 24 months living virtually. We are very proud of our lineup for TMA 2021 and the information that it brings to the people doing the work on the front lines. You simply cannot get this anywhere else but from TMA,” said TMA President and CEO Chris Greer.

    The program includes live keynote presentations with Q&As by FDA CTP Director Mitch Zeller and CTP Office of Science Director Matt Holman followed by these panel discussions:

    • An Applicant’s Perspective: Reflections on Where We Stand – Moderated by Jim Solyst, industry consultant
    • The Marketplace Perspective: Adjusting to Change – Moderated by Mary Szarmach, Smoker Friendly
    • Early and Often: Navigating Your Path to Market – Moderated by Jennifer Smith, Altria Client Services
    • Connecting U.S. and Global Trends – Moderated by Jeannie Cameron, JCIC International Consultants

    “2021 was another challenging year for in-person events; following feedback from our members and guests, TMA elected to hold our annual conference virtually and will host our annual meeting and conference in 2022 as an in-person and virtual event,” said Greer.

    Christopher Greer is the president and CEO of TMA, a position he has held since March 2017. Greer began his career in the regulatory compliance and government affairs sector at Verizon Wireless. In 2010, Greer joined Japan Tobacco International (JTI) USA as regulatory affairs manager. In 2016, Greer was named to the JTI USA executive team as director and department head of corporate affairs and communications for the U.S., Caribbean and Central American markets. Greer’s tobacco experience includes leading U.S. Food and Drug Administration compliance for the U.S. market, business development in the Caribbean and Central America, government relations, international trade and customs, and streamlining internal processes to reduce compliance costs.

    For this year’s TMA Annual Conference, we felt it was important to capitalize on the breadth and depth of speakers and expertise that only TMA can bring and condense that into the most important topics for our attendees who have also spent the last 24 months living virtually.

    TMA 2020 | Digital was TMA’s first virtual only event and featured an expansive program of hour-long discussions and keynotes spread over several months. TMA 2021 takes the best of that format along with a super-charged program aimed directly at those most active in the industry and stakeholder community.

    Registration will open on or about Nov. 1 and run up through the conference commencement. Registered attendees will have the ability to view content for 30 days following the end of TMA 2021 and TMA members will have access for longer still. Registration is $299 for non-members and $199 for TMA members.

    For more information, please see tma.org or send inquiries to tma@tma.org.

  • England Paves Way for E-Cig Prescriptions

    England Paves Way for E-Cig Prescriptions

    Photo: goodmanphoto

    Doctors in England may soon be prescribing e-cigarettes to help people stop smoking tobacco, according to a news story published by the Department of Health Social Care and the Office for Health Improvement and Disparities. The Medicines and Healthcare products Regulatory Agency (MHRA) is publishing updated guidance that paves the way for medicinally licensed e-cigarette products to be prescribed for smoking cessation.

    Manufacturers can approach the MHRA to submit their products to go through the same regulatory approvals process as other medicines available on the health service.

    This could mean England becomes the first country in the world to prescribe e-cigarettes licensed as a medical product.

    If a product receives MHRA approval, clinicians could then decide on a case-by-case basis whether it would be appropriate to prescribe an e-cigarette to NHS patients to help them quit smoking. It remains the case that non-smokers and children are strongly advised against using e-cigarettes.

    This country continues to be a global leader on healthcare, whether it’s our Covid-19 vaccine rollout saving lives or our innovative public health measures reducing people’s risk of serious illness.

    If a product receives MHRA approval, clinicians could then decide on a case-by-case basis whether it would be appropriate to prescribe an e-cigarette to NHS patients to help them quit smoking. It remains the case that non-smokers and children are strongly advised against using e-cigarettes.

    E-cigarettes contain nicotine and are not risk free, but expert reviews from the U.K. and U.S. have been clear that the regulated e-cigarettes are less harmful than smoking. A medicinally licensed e-cigarette would have to pass even more rigorous safety checks.

    Smoking remains the leading preventable cause of premature death and while rates are at record low levels in the U.K., there are still around 6.1 million smokers in England. There are also stark differences in rates across the country, with smoking rates in Blackpool (23.4 percent) and Kingston upon Hull (22.2 percent) poles apart from rates in wealthier areas such as Richmond upon Thames (8 percent).

    E-cigarettes were the most popular aid used by smokers trying to quit in England in 2020, according to the Department of Health and Social Care. E-cigarettes have been shown to be highly effective in supporting those trying to quit, with 27.2 percent of smokers using them compared with 18.2 percent using nicotine replacement therapy products such as patches and gum.

    Some of the highest success rates of those trying to quit smoking are among people using an e-cigarette to kick their addiction alongside local Stop Smoking services, with up to 68 percent successfully quitting in 2020 -2021.

    We fully welcome the news that the NHS in England is exploring opportunities to prescribe vaping products to help people quit smoking.

    “This country continues to be a global leader on healthcare, whether it’s our Covid-19 vaccine rollout saving lives or our innovative public health measures reducing people’s risk of serious illness,” said Health and Social Care Secretary Sajid Javid.

    “Opening the door to a licensed e-cigarette prescribed on the NHS has the potential to tackle the stark disparities in smoking rates across the country, helping people stop smoking wherever they live and whatever their background.”

    Vapor industry representative welcomed the prospect of e-cigarettes on prescription.

    “We fully welcome the news that the NHS in England is exploring opportunities to prescribe vaping products to help people quit smoking,” said Doug Mutter, director of VPZ, the U.K.’s largest vaping retailer with 157 stores throughout the country.

    “The pandemic has triggered an increase in smoking rates and the public health problem has been compounded by funding cuts for NHS stop smoking services and local support groups.

     “However this progressive and innovative approach being considered by the NHS in England has the potential to reverse this damage and bring new momentum to our ambitions of becoming a smoke free nation by 2030.”

    The government deserves huge praise for taking this bold decision to look more closely at the use of vaping when it comes to smoking cessation and for taking an evidence-based, science-led approach.

    “The government deserves huge praise for taking this bold decision to look more closely at the use of vaping when it comes to smoking cessation and for taking an evidence-based, science-led approach rather than the nonsensical anti-vaping, anti-harm reduction stance of some countries,” said John Dunne, Director General of the U.K. Vaping Industry Association.

    “This announcement by the Department for Health is just the latest in a long line of breakthroughs for those of us who for years have advocated vaping as the best and most effective method for people looking to quit smoking.”

  • India Slashes Penalty for Overproduction

    India Slashes Penalty for Overproduction

    Photo: Tobacco Reporter archive

    India’s Ministry of Commerce and Industry has cut the penalty on “excess” tobacco produced during the 2021-2022 cropping season by 50 percent to help growers compete on the world market, reports The Hindu.  

    To prevent overproduction, Indian regulators set a crop size target prior to each production season. Growers who exceed the authorized volume must pay a penalty.

    Following the penalty reduction, authorized growers must pay INR1 ($0.01) per kg and 5 percent of the value of their excess production during the 2021-22 cropping season. However, unregistered growers have to pay the old rates.

    Tobacco growers welcomed the decision. “We can confidently raise the crop without fearing the penalty to achieve the economies of scale,” said B. Ramaanjaneyulu.

    The Tobacco Board authorized production on 27,818 hectares in the Southern Light Soils region and 22,014 hectares in the Southern Black Soils region of Andhra Pradesh.

  • JT Group ups Forecast on Robust Nine Months

    JT Group ups Forecast on Robust Nine Months

    Masamichi Terabatake
    (Photo: JT Group)

    The JT Group reported year-to-date revenue of ¥1.77 trillion ($15.5 billion), up 10.9 percent over those in the first nine months of 2020. Adjusted operating profit at constant currency increased 21.9 percent to ¥538.1 billion. On a reported basis, adjusted operating profit increased 23 percent to ¥542.9 billion. The group’s operating profit was ¥480.7 billion, up 23.2 percent over last year’s period. Based on its performance, the JT Group increased its financial forecasts for the full year.

    “The JT Group reported a robust year-to-date performance, driven by strong momentum across the tobacco businesses. Our volume performance continued to be strong, driven by market share increases and stable industry volumes from longer than expected travel restrictions,” said JT Group President and CEO Masamichi Terabatake in a statement.

    “We revised our full year forecasts upward, reflecting the robust results delivered in the first nine months of 2021 and also favorable currency trends. Following the upward revisions of our forecast, we are pleased to inform our plan to raise our annual dividend guidance by ¥10 to ¥140 per share.

    “In Japan, we have received very encouraging feedback from consumers on Ploom X. However, the global semi-conductor shortage is impacting production of heated tobacco devices, so for the remainder of the year, we will prioritize the device supply in the Japanese market where we have already launched Ploom X. We will continue to strive to secure share growth.

    “In addition, with our one tobacco business new operating model from January 2022, we will further strengthen our business foundation as well as build a more agile and consumer-centric organization.”

  • Farmers Rally Against Contracting Plan

    Farmers Rally Against Contracting Plan

    Photo: Tobacco Reporter archive

    A plan to introduce tobacco contract farming has run into fierce opposition among leaf growers in India, reports The Times of India. During a massive gathering in Guntur on the occasion World Tobacco Growers’ Day, farmers demanded that the central government abandon its proposals, saying that contracting would put growers at risk of exploitation.

    “It’s going to have a disastrous effect on the livelihood of millions of growers,” predicted Gadde Seshagiri Rao, former vice president of the Tobacco Board.

    Virginia tobacco farmers association president Karatam Venkata said the existing auction system works well because it provides growers with assured payment though the Tobacco Board while contract farming results in delayed payments. In contract farming, he added, farmers’ livelihoods would be at the mercy of traders.

    Growers also praised the fairness and transparency of the auction system, which they said provided greater market stability than contracting. The tobacco farmers were particularly incensed that the government had made its proposal without consulting them.

    Contract farming has been gaining momentum globally at the expense of auction sales as leaf traders faced with ever-stricter compliance requirements seek greater control over the production process.

  • Essentra ‘Reviewing’ its Filter Business

    Essentra ‘Reviewing’ its Filter Business

    Photo: Essentra

    Essentra is reviewing strategic options for its tobacco filters business, as it looks to focus on its component-making division for other sectors, reports Reuters.

    The company, which has supplied filters to cigarette manufacturers for more than 80 years, said the review is expected to finish in the second quarter of 2022.

    According to Reuters, Essentra has concluded that it should become a pure play global components business over time and that the strategic review of the filter division was the first step to achieving that.

    Essentra’s filter division reported a 2.8 percent rise in revenue in the three months to September.

    The company said its components business, which makes plastic molded, vinyl dip molded and metal items used in equipment manufacturing, automotive and electronics, performed strongly in the quarter.

    The tobacco industry is facing heavy scrutiny and mounting regulations due to the health risks of its products.

    Essentra declined to speculate on whether the firm would divest it cigarette filters business. “As of now, we are unable to comment on the final outcome of the strategic review which is targeted to conclude by second quarter 2022 as it is still ongoing,” a company spokesman told Tobacco Reporter.

  • Prosecution for Exchanging Price Info

    Prosecution for Exchanging Price Info

    Photo: promesaartstudio

    The Belgian Competition Authority (BCA) has decided to prosecute Philip Morris Benelux, Établissements L. Lacroix Fils, JT International Company Netherlands and British American Tobacco Belgium for the exchange of information on prices between competitors.

    Together, the accused parties account for 90 percent of cigarette consumption in Belgium. The competition prosecutor alleges the existence of anticompetitive practices that lasted for several years and consisted of repeated exchanges of information on their future prices through wholesalers.

    According to a BCA press release, the manufacturers sent information on their own future prices to their wholesalers and, through the wholesalers, received information on the future prices of their competitors.

    Such conduct may be contrary to Article IV.1 CEL and Article 101 TFEU, according to the BCA.  

    This case will now be examined by the Competition College. The defendants will have an opportunity to defend themselves against these objections in front of the college. The parties will be able to submit written comments to the Competition College and will be heard at a hearing.

  • U.S. Sales up for the First Time in 20 Years

    U.S. Sales up for the First Time in 20 Years

    Photo: akolosov.art

    The number of cigarettes that the largest cigarette companies in the United States sold to wholesalers and retailers nationwide increased from 202.9 billion in 2019 to 203.7 billion in 2020, according to the most recent Federal Trade Commission Cigarette Report. This represents the first time annual cigarette sales have increased in 20 years.

    According to the 2020 Smokeless Tobacco Report, smokeless tobacco sales increased from 126 million pounds in 2019 to 126.9 million pounds in 2020. The revenue from those sales rose from $4.53 billion in 2019 to $4.82 billion in 2020. For the first time, the Commission is reporting sales of nicotine lozenges or nicotine pouches not containing tobacco. In 2020, the companies sold 140.7 million units of such products in the United States, for $420.5 million.

    The amount spent on cigarette advertising and promotion increased from $7.62 billion in 2019 to $7.84 billion in 2020. Price discounts paid to cigarette retailers ($6.07 billion) and wholesalers ($876 million) were the two largest expenditure categories in 2020. Combined spending on price discounts accounted for 88.5 percent of industry spending.

    Spending on advertising and promotion by the major manufacturers of smokeless tobacco products in the U.S. decreased from $576.1 million in 2019 to $567.3 million in 2020. As with cigarettes, price discounts made up the two largest spending categories, with $296.6 million paid to retailers and $83.5 million paid to wholesalers. Combined spending on price discounts totaled $380.1 million—or 67.4 percent of all spending in 2020, up from the $376 million spent in 2019.

    For the first time, the 2020 data include information on the flavors of the companies’ smokeless tobacco products. Menthol flavored smokeless tobacco products comprised more than half of all sales revenues (54.5 percent); tobacco flavored products (that is, no added flavor) comprised 43.4 percent; and fruit flavored smokeless tobacco products comprised 2.5 percent.

    The Commission has issued the Cigarette Report periodically since 1967 and the Smokeless Tobacco Report periodically since 1987. Given the concerning trends highlighted in this report, including the first increase in cigarette sales in two decades, the Commission will continue to expand its approach in reporting shifts in the tobacco industry. The FTC also will use the newly captured data regarding smokeless tobacco products to align the Commission’s enforcement efforts with the emergent realities in the tobacco industry.